Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

OBJECTIVE: Blood tests to monitor disease activity, attack severity, or treatment impact in neuromyelitis optica spectrum disorder (NMOSD) have not been developed. This study investigated the relationship between serum glial fibrillary acidic protein (sGFAP) concentration and NMOSD activity and asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktas, Orhan, Smith, Michael A., Rees, William A., Bennett, Jeffrey L., She, Dewei, Katz, Eliezer, Cree, Bruce A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252046/
https://www.ncbi.nlm.nih.gov/pubmed/33724534
http://dx.doi.org/10.1002/ana.26067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252046/
https://www.ncbi.nlm.nih.gov/pubmed/33724534
http://dx.doi.org/10.1002/ana.26067

Ejemplares similares